Item 1A. RISK FACTORS

RISK FACTORS

Investing in The Hartford involves risk. In deciding whether to invest in The Hartford, you should carefully consider the risk factors disclosed in Item 1A of Part I of the Company's Annual Report on Form 10-K for the year ended December 31, 2023, (collectively the "Company's Risk Factors" or individually, the "Company's Risk Factor"), which is incorporated herein by

reference, any of which could have a significant or material adverse effect on the business, financial condition, operating results or liquidity of The Hartford. This information should be considered carefully together with the other information contained in this report and the other reports and materials filed by The Hartford with the SEC.


Item 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

PURCHASES OF EQUITY SECURITIES BY THE ISSUER

Repurchases of common stock by the Company during the quarter ended March 31, 2024 are set forth below. During the period from April 1, 2024 to April 24, 2024, the Company repurchased 1.1 million shares for $113.


Repurchases of Common Stock by the Issuer for the Three Months Ended March 31, 2024
Period	Total Number of Shares Purchased [1]	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs [2]
					(in millions)
January 1, 2024 - January 31, 2024	1,508,128	$	84.58	1,501,029	$	1,222
February 1, 2024 - February 29, 2024	1,916,318	$	94.17	1,119,428	$	1,119
March 1, 2024 - March 31, 2024	1,244,304	$	99.64	1,226,596	$	998
Total	4,668,750	$	92.53	3,847,053

[1]Includes 821,697 shares in net settlement of employee tax withholding obligations related to equity awards under the Company's incentive stock plans, which were not part of publicly announced share repurchase authorizations. The Company paid an average price per share of $95.58 in employee tax withholding obligations related to net share settlements in the three months ended March 31, 2024.

[2]In July, 2022, the Board of Directors approved a share repurchase authorization for up to $3.0 billion effective from August 1, 2022 to December 31, 2024. The timing of any repurchases is dependent on several factors, including the market price of the Company's securities, the Company's capital position, consideration of the effect of any repurchases on the Company's financial strength or credit ratings, the Company's blackout periods, and other considerations.


Item 5.

OTHER INFORMATION

On February 8, 2024, Jonathan R. Bennett, Executive Vice President and Head of Group Benefits, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the potential sale of up to 7,688.108 shares of the Company's common stock between

May 8, 2024 and January 31, 2025 (or the date on which all shares have been sold) subject to certain conditions.

On February 8, 2024, Beth A. Costello, Executive Vice President and Chief Financial Officer, adopted a Rule 10b5-1 trading


Table of Contents

Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. Other Information